The overexpression of CAV1 breast cancer-associated mutant, P132L, results in the attenuation of GLP-1 binding activity, regulating the downstream cellular trafficking and signaling activity of GLP-1R [194]. This evidence concerns the gene GLP1R and breast cancer.